“Application of Nanocarrier-Based Targeted Drug Delivery in the Treatment of Liver Fibrosis and Vascular Diseases”, J. Med. Life Sci., vol. 1, no. 2, pp. 63–69, Apr. 2025, doi: 10.71222/bc9c9s73.